The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InReflecting a shift in long-term growth expectations for the insurance sector, Dowling & Partners reduced its FY2026 earnings per share estimate for MetLife from $9.95 to $9.90. This revised figure sits slightly below the broader market consensus of $9.98 per share. Despite the downward revision, MetLife recently reported a quarterly EPS of $2.42, beating analyst expectations alongside a 2.7% year-over-year increase in revenue.
The minor adjustment suggests a cautious outlook on future profitability even as MetLife outperformed peers in recent cycles, where competitors like Prudential Financial saw mixed growth in asset management segments. Per market data, MET shares continue to trade at levels reflecting relative stability compared to recent financial sector volatility, supported by a "Moderate Buy" consensus rating based on balance sheet strength.
MetLife (MET) closed at $92.54 on July 14, 2026, after trading within a daily range of $92.21 to $93.81. Investors are now monitoring macroeconomic catalysts impacting the insurance industry, including the recently released FOMC Minutes, for further clarity on interest rate trajectories which significantly influence the investment yields of major insurers.